Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment

Biomaterials

Volumn 34, Issue 33, 2013, Pages 8511-8520

  Cui, Yanna ^a,b   Xu, Qingxing ^b   Chow, Pierce Kah Hoe ^c,d,e   Wang, Deping ^a   Wang, Chi Hwa ^b  

^a TONGJI UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Brain glioma; Doxorubicin; Magnetic silica PLGA nanoparticles; Paclitaxel; Transferrin

Indexed keywords

BRAIN GLIOMATA; DOXORUBICIN; PACLITAXEL; PLGA NANOPARTICLES; TRANSFERRIN;

BLOOD; COPOLYMERS; MAGNETIC FIELDS; MAMMALS; NANOPARTICLES; SILICA; TUMORS;

NANOMAGNETICS;

DOXORUBICIN; LIGAND; NANOPARTICLE; PACLITAXEL; SILICON DIOXIDE; TRANSFERRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; GLIOMA; IN VITRO STUDY; IN VIVO STUDY; MAGNETIC FIELD; MOUSE; NONHUMAN; PRIORITY JOURNAL; XENOGRAFT;

MUS; MUS MUSCULUS;

BRAIN GLIOMA; DOXORUBICIN; MAGNETIC SILICA PLGA NANOPARTICLES; PACLITAXEL; TRANSFERRIN;

ANIMALS; CELL LINE, TUMOR; DOXORUBICIN; GLIOMA; HUMANS; MICE; MICE, NUDE; NANOPARTICLES; PACLITAXEL;

EID: 84881669479     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.075     Document Type: Article

References (43)

1. Zhang P., Hu L., Yin Q., Feng L., Li Y. Transferrin-modified c[RGDfK]-paclitaxel loaded hybrid micelle for sequential blood-brain barrier penetration and glioma targeting therapy. Mol Pharm 2012, 9:1590-1598.
2. Mangiola A., Anile C., Pompucci A., Capone G., Rigante L., De Bonis P. Glioblastoma therapy: going beyond Hercules Columns. Expert Rev Neurother 2010, 10:507-514.
3. Xin H., Sha X., Jiang X., Zhang W., Chen L., Fang X. Anti-glioblastoma efficacy and safety of paclitaxel-loading angiopep-conjugated dual targeting PEG-PCL nanoparticles. Biomaterials 2012, 33:8167-8176.
4. Ding H., Inoue S., Ljubimov A.V., Patil R., Portilla-Arias J., Hu J., et al. Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release. Proc Natl Acad Sci U S A 2010, 107:18143-18148.
5. Zhan C., Wei X., Qian J., Feng L., Zhu J., Lu W. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel invitro and invivo. JControl Release 2012, 160:630-636.
6. Yue J., Liu S., Wang R., Hu X., Xie Z., Huang Y., et al. Transferrin-conjugated micelles: enhanced accumulation and antitumor effect for transferrin-receptor-overexpressing cancer models. Mol Pharm 2012, 9:1919-1931.
7. Ojima I. Modern molecular approaches to drug design and discovery. Acc Chem Res 2008, 41:2-3.
8. Thorpe P.E. Vascular targeting agents as cancer therapeutics. Clin Cancer Res 2004, 10:415-427.
9. Parren P.W., van de Winkel J.G. An integrated science-based approach to drug development. Curr Opin Immunol 2008, 20:426-430.
10. Pang Z., Feng L., Hua R., Chen J., Gao H., Pan S., et al. Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats. Mol Pharm 2010, 7:1995-2005.
11. Xin H., Jiang X., Gu J., Sha X., Chen L., Law K., et al. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials 2011, 32:4293-4305.
12. Jones A.R., Shusta E.V. Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res 2007, 24:1759-1771.
13. Martell L.A., Agrawal A., Ross D.A., Muraszko K.M. Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors. Cancer Res 1993, 53:1348-1353.
14. Ying X., Wen H., Lu W.L., Du J., Guo J., Tian W., et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. JControl Release 2010, 141:183-192.
15. Pang Z., Gao H., Yu Y., Guo L., Chen J., Pan S., et al. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin. Bioconjug Chem 2011, 22:1171-1180.
16. Vivero-Escoto J.L., Slowing I.I., Trewyn B.G., Lin V.S. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 2010, 6:1952-1967.
17. Na H.K., Kim M.H., Park K., Ryoo S.R., Lee K.E., Jeon H., et al. Efficient functional delivery of siRNA using mesoporous silica nanoparticles with ultralarge pores. Small 2012, 8:1752-1761.
18. Liu Q., Zhang J., Xia W., Gu H. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles. Nanoscale 2012, 4:3415-3421.
19. Yu L.L., Bi H. Facile synthesis and magnetic property of iron oxide/MCM-41 mesoporous silica nanospheres for targeted drug delivery. JAppl Phys 2012, 111:07B514.
20. Kong S.D., Lee J., Ramachandran S., Eliceiri B.P., Shubayev V.I., Lal R., et al. Magnetic targeting of nanoparticles across the intact blood-brain barrier. JControl Release 2012, 164:49-57.
21. Guo J., Gao X., Su L., Xia H., Gu G., Pang Z., et al. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 2011, 32:8010-8020.
22. Ranganath S.H., Fu Y., Arifin D.Y., Kee I., Zheng L., Lee H.S., et al. The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice. Biomaterials 2010, 31:5199-5207.
23. Cui Y., Dong H., Cai X., Wang D., Li Y. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release. ACS Appl Mater Interfaces 2012, 4:3177-3183.
24. Zhang Z., Wang L., Wang J., Jiang X., Li X., Hu Z., et al. Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv Mater 2012, 24:1418-1423.
25. Heo D.N., Yang D.H., Moon H.J., Lee J.B., Bae M.S., Lee S.C., et al. Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. Biomaterials 2012, 33:856-866.
26. Xi G., Hu X., Wu B., Jiang H., Young C.Y., Pang Y., et al. Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells. Cancer Lett 2011, 307:141-148.
27. Sgadari C., Toschi E., Palladino C., Barillari G., Carlei D., Cereseto A., et al. Mechanism of paclitaxel activity in Kaposi's sarcoma. JImmunol 2000, 165:509-517.
28. Ramírez L.P., Landfester K. Magnetic polystyrene nanoparticles with a high magnetite content obtained by miniemulsion processes. Macromol Chem Phys 2003, 204:22-31.
29. Zhang J., Li X., Rosenholm J.M., Gu H.C. Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles. JColloid Interface Sci 2011, 361:16-24.
30. Huang L., Dolai S., Raja K., Kruk M. "Click" grafting of high loading of polymers and monosaccharides on surface of ordered mesoporous silica. Langmuir 2010, 26:2688-2693.
31. Hoshikawa Y., Yabe H., Nomura A., Yamaki T., Shimojima A., Okubo T. Mesoporous silica nanoparticles with remarkable stability and dispersibility for antireflective coatings. Chem Mater 2010, 22:12-14.
32. Soto-Cantu E., Cueto R., Koch J., Russo P.S. Synthesis and rapid characterization of amine-functionalized silica. Langmuir 2012, 28:5562-5569.
33. Fan D., De Rosa E., Murphy M.B., Peng Y., Smid C.A., Chiappini C., et al. Mesoporous silicon-PLGA composite microspheres for the double controlled release of biomolecules for orthopedic tissue engineering. Adv Funct Mater 2012, 22:282-293.
34. Huang S., Fan Y., Cheng Z., Kong D., Yang P., Quan Z., et al. Magnetic mesoporous silica spheres for drug targeting and controlled release. JPhys Chem C 2009, 113:1775-1784.
35. Kuo Y.C., Lin P.I., Wang C.C. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles. Nanomedicine 2011, 6:1011-1026.
36. Das M., Dilnawaz F., Sahoo S.K. Targeted nutlin-3a loaded nanoparticles inhibiting p53-MDM2 interaction: novel strategy for breast cancer therapy. Nanomedicine 2011, 6:489-507.
37. Li Y., He H., Jia X., Lu W.L., Lou J., Wei Y. Adual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. Biomaterials 2012, 33:3899-3908.
38. Fernandez C.A., Baumhover N.J., Duskey J.T., Khargharia S., Kizzire K., Ericson M.D., et al. Metabolically stabilized long-circulating PEGylated polyacridine peptide polyplexes mediate hydrodynamically stimulated gene expression in liver. Gene Ther 2011, 18:23-37.
39. Thorek D.L., Chen A.K., Czupryna J., Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 2006, 34:23-38.
40. Lee P.W., Hsu S.H., Wang J.J., Tsai J.S., Lin K.J., Wey S.P., et al. The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles. Biomaterials 2010, 31:1316-1324.
41. Linhart W., Peters F., Lehmann W., Schwarz K., Schilling A.F., Amling M., et al. Biologically and chemically optimized composites of carbonated apatite and polyglycolide as bone substitution materials. JBiomed Mater Res 2001, 54:162-171.
42. Shapiro B., Dormer K., Rutel I.B. Atwo-magnet system to push therapeutic nanoparticles. AIP Conf Proc 2010, 1311:77-88.
43. Yue J., Liu S., Mo G., Wang R., Jing X. Active targeting and fluorescence-labeled micelles: preparation, characterization and cellular uptake evaluation. JControl Release 2011, 152:e258-e260.